Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cerebrovascular74 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01190 | 34835476 | Microorganisms | Impact of Helicobacter pylori-Related Metabolic Syndrome Parameters on Arterial Hypertension. | 2021 | Details |
| A01215 | 34827579 | Biomolecules | Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms. | 2021 | Details |
| A01293 | 34799486 | Curr Opin Lipidol | Fatty liver and cerebrovascular disease: plausible association and possible mechanisms. | 2022 | Details |
| A01395 | 34762106 | JAMA | Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01990 | 34537182 | Anal Biochem | Cerebrovascular alterations in NAFLD: Is it increasing our risk of Alzheimer's disease? | 2021 | Details |
| A02479 | 34359438 | Foods | Comparison of Egg Yolk and Soybean Phospholipids on Hepatic Fatty Acid Profile and Liver Protection in Rats Fed a High-Fructose Diet. | 2021 | Details |
| A02482 | 34358793 | Curr Opin Pharmacol | Very-low-calorie ketogenic diet: An alternative to a pharmacological approach to improve glycometabolic and gonadal profile in men with obesity. | 2021 | Details |
| A04208 | 33713286 | Intern Emerg Med | Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study. | 2021 | Details |
| A04281 | 33679048 | J Clin Exp Hepatol | The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers. | 2020 | Details |
| A04772 | 33511140 | Front Med (Lausanne) | Distinct Cause of Death Profiles of Hospitalized Non-alcoholic Fatty Liver Disease: A 10 Years' Cross-Sectional Multicenter Study in China. | 2021 | Details |
| A05507 | 33224584 | Am J Cardiovasc Dis | Sex differences in cardiovascular diseases and associated risk factors in non-alcoholic steatohepatitis. | 2020 | Details |
| A06889 | 32708059 | Biomedicines | Depression and Cognitive Impairment-Extrahepatic Manifestations of NAFLD and NASH. | 2020 | Details |
| A06971 | 32683094 | Ann Hepatol | Cerebral hemodynamics in the non-alcoholic fatty liver. | 2020 | Details |
| A07173 | 32592869 | J Neurol Sci | Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers. | 2020 | Details |
| A07497 | 32472598 | FASEB J | Propionic acid and not caproic acid, attenuates nonalcoholic steatohepatitis and improves (cerebro) vascular functions in obese Ldlr-/- .Leiden mice. | 2020 | Details |
| A07779 | 32356922 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. | 2020 | Details |
| A08910 | 31941880 | Med Sci Monit | Electrocardiogram-Based R Wave Pulse Wave Index for Assessment of Carotid Atherosclerosis. | 2020 | Details |
| A09695 | 31644993 | J Neurol Sci | Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke. | 2019 | Details |
| A10394 | 31357643 | Int J Mol Sci | Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic Syndrome. | 2019 | Details |
| A10814 | 31176631 | Dig Liver Dis | Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. | 2019 | Details |
| A11021 | 31080056 | Ann Hepatol | Non-alcoholic fatty liver disease and neurological defects. | 2019 | Details |
| A11042 | 31071367 | J Hepatol | Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study. | 2019 | Details |
| A11194 | 31004758 | Clin Gastroenterol Hepatol | Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies. | 2019 | Details |
| A11774 | 30755685 | Sci Rep | Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals. | 2019 | Details |
| A12280 | 30536602 | Liver Int | Atrial fibrillation is highly prevalent yet undertreated in patients with biopsy-proven nonalcoholic steatohepatitis. | 2018 | Details |
| A12288 | 30528844 | Clin Gastroenterol Hepatol | FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage. | 2018 | Details |
| A12624 | 30360566 | J Clin Med | Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14147 | 29564059 | Gastroenterol Hepatol Bed Bench | Is treatment of fatty liver effective on reducing carotid intima media thickness; a cohort study. | 2018 | Details |
| A14416 | 29416808 | Oncotarget | Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis. | 2017 | Details |
| A14448 | 29404500 | Hepatol Commun | Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A14867 | 29199410 | Diabetes Metab J | Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases. | 2017 | Details |
| A14914 | 29175651 | Atherosclerosis | Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis. | 2017 | Details |
| A15115 | 29087391 | Am J Gastroenterol | Prognostic Value of Controlled Attenuation Parameter by Transient Elastography. | 2017 | Details |
| A17344 | 27833378 | World J Gastroenterol | Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study. | 2016 | Details |
| A20367 | 26011302 | Metab Syndr Relat Disord | Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20651 | 25832152 | Med J Aust | The imperative to prevent diabetes complications: a broadening spectrum and an increasing burden despite improved outcomes. | 2015 | Details |
| A20709 | 25788195 | Hepatol Int | Association between retinal artery lesions and nonalcoholic fatty liver disease. | 2015 | Details |
| A20731 | 25772181 | Endocr Metab Immune Disord Drug Targets | Adiponectin as a Target in Obesity-related Inflammatory State. | 2015 | Details |
| A21101 | 25536561 | Probl Radiac Med Radiobiol | Structure of comorbid diseases in patients with non-alcoholic fatty liver disease, exposed to ionizing radiation as a result of the Chornobyl NPP accident. | 2014 | Details |
| A22324 | 24660702 | AJR Am J Roentgenol | Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications. | 2014 | Details |
| A22581 | 24445216 | J Hepatol | Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. | 2014 | Details |
| A22991 | 24132155 | Int J Mol Sci | Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). | 2013 | Details |
| A23100 | 24040875 | Curr Pharm Des | The role of statins in the treatment of type 2 diabetes mellitus: an update. | 2014 | Details |
| A23697 | 23557879 | Nutr Metab Cardiovasc Dis | The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. | 2013 | Details |
| A23709 | 23548197 | J Hepatol | Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats. | 2013 | Details |
| A23772 | 24843641 | J Diabetes Investig | Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas. | 2013 | Details |
| A23835 | 23439508 | Acta Med Okayama | A prospective study of long-term outcomes in female patients with nonalcoholic steatohepatitis using age- and body mass index-matched cohorts. | 2013 | Details |
| A24467 | 22868011 | J Coll Physicians Surg Pak | Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis? | 2012 | Details |
| A25339 | 21948267 | Obes Surg | Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. | 2011 | Details |
| A25472 | 21795844 | J Endocrinol Invest | Increased prevalence of cardiovascular disease in Type 1 diabetic patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A26347 | 20619918 | J Hepatol | Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. | 2010 | Details |
| A27020 | 19337018 | J Endocrinol Invest | Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease. | 2009 | Details |
| A27844 | 17277038 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. | 2007 | Details |
| A28040 | 16620269 | Diabet Med | Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. | 2006 | Details |
| A36018 | 19195795 | Med Hypotheses | Getting the iron out: phlebotomy for Alzheimer's disease? | 2009 | Details |
| A36283 | 18525306 | Am J Clin Oncol | Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial. | 2008 | Details |
| A42255 | 35088389 | Hepatol Int | Non-alcoholic fatty liver disease in cerebrovascular disease: a bystander or a real risk factor? | 2022 | Details |
| A44078 | 29936174 | Metabolism | Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. | 2018 | Details |
| A44838 | 27116685 | Pathobiology | Chitotriosidase: A New Inflammatory Marker in Diabetic Complications. | 2016 | Details |
| A44932 | 26728014 | J Nucl Cardiol | Hepatic FDG uptake in patients with NAFLD: An important prognostic factor for cardio-cerebrovascular events? | 2016 | Details |
| A47884 | 30072250 | Surgery | Early mortality after liver transplantation: Defining the course and the cause. | 2018 | Details |
| A48530 | 34647189 | Diabetes Ther | Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant? | 2021 | Details |
| A48844 | 26763484 | Liver Int | Chronic hepatitis C virus infection, a new cardiovascular risk factor? | 2016 | Details |
| A49395 | 35765060 | Cell Biosci | Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. | 2022 | Details |
| A50101 | 35528835 | Front Cardiovasc Med | Salvia miltiorrhiza Bge. (Danshen) in the Treating Non-alcoholic Fatty Liver Disease Based on the Regulator of Metabolic Targets. | 2022 | Details |
| A50289 | 35443336 | J Assoc Physicians India | Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Morbidity in Polycystic Ovarian Syndrome. | 2022 | Details |
| A50768 | 35273712 | Am J Transl Res | Multivariable-adjusted trends in mortality due to alcoholic liver disease among adults in the United States, from 1999-2017. | 2022 | Details |
| A51089 | 35803839 | J Diabetes Complications | Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus. | 2022 | Details |
| A51521 | 35655263 | Cardiovasc Diabetol | Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex. | 2022 | Details |
| A51582 | 34877669 | Aliment Pharmacol Ther | Skipping breakfast is associated with an increased long-term cardiovascular mortality in metabolic dysfunction-associated fatty liver disease (MAFLD) but not MAFLD-free individuals. | 2021 | Details |
| A51920 | 33233602 | Int J Mol Sci | Lipodystrophies-Disorders of the Fatty Tissue. | 2020 | Details |
| A52373 | 28052632 | Liver Int | Impact of hepatitis C virus therapy on metabolism and public health. | 2017 | Details |
| A52961 | 18773755 | G Ital Cardiol (Rome) | [Pharmacological therapy of obesity]. | 2008 | Details |
| A53031 | 16996649 | Neurobiol Aging | A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. | 2006 | Details |